Exagen to Announce Third Quarter 2023 Financial Results on November 13, 2023
30 Outubro 2023 - 5:05PM
Exagen Inc. (Nasdaq: XGN), a leading provider of
autoimmune testing solutions, will release financial results for
the quarter ended September 30, 2023, after the market close on
Monday, November 13, 2023. John Aballi, Exagen’s President and
Chief Executive Officer, and Kamal Adawi, Chief Financial Officer,
will host a conference call to review the Company’s results at 4:30
PM ET (1:30 PM PT).
Interested parties may access the conference call by dialing
(201) 389-0918 (U.S.) or (877) 407-0890 (international).
Participants wishing to access the call via webcast should use the
link posted on the Exagen investor relations website at
investors.exagen.com.
A replay of the conference call will be available until Monday,
November 27, 2023, at 11:59 PM ET (8:59 PM PT). Interested parties
may access the replay of the conference call by dialing (201)
612-7415 (U.S.) or (877) 660-6853 (international) using passcode
13741926. Additionally, a recording of the webcast will be
available using the link on the Exagen investor relations website
approximately one hour after the call concludes.
About Exagen Inc.
Exagen is a leading provider of autoimmune testing and its
purpose as an organization is to provide clarity in autoimmune
disease decision making with the goal of improving patients’
clinical outcomes. Exagen is located in San Diego County,
California.
For more information, please visit Exagen.com and
follow @ExagenInc on Twitter.
CONTACTS:
Investor RelationsExagen Inc.Ryan
Douglasrdouglas@exagen.com760.560.1525
CompanyExagen Inc.Kamal Adawi, Chief Financial
Officerkadawi@exagen.com
Exagen (NASDAQ:XGN)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Exagen (NASDAQ:XGN)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024